Transactivators Zta and Rta of Epstein-Barr virus promote G0/G1 to S transition in Raji cells: A novel relationship between lytic virus and cell cycle

Molecular Immunology

Volumn 47, Issue 9, 2010, Pages 1783-1792

  Guo, Qingwei ^a   Qian, Lu ^b   Guo, Liang ^b   Shi, Ming ^b   Chen, Changguo ^b   Lv, Xin ^c   Yu, Ming ^b   Hu, Meiru ^b   Jiang, Guosheng ^a   Guo, Ning ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; EBV; Raji cells; Rta; Zta

Indexed keywords

IMMEDIATE EARLY PROTEIN BZLF1; PROTEASOME; PROTEIN P21; PROTEIN P53; PROTEIN RTA; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL POPULATION; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; ENZYME DEGRADATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAJI CELL; VIRUS CELL INTERACTION; VIRUS REACTIVATION;

BLOTTING, WESTERN; BURKITT LYMPHOMA; BUTYRATES; CELL CYCLE; CELL LINE, TUMOR; E2F1 TRANSCRIPTION FACTOR; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMEDIATE-EARLY PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S PHASE; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 77952322937     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.02.017     Document Type: Article

References (46)

1. Adamson A.L., Darr D., Holley-Guthrie E., Johnson R.A., Mauser A., Swenson J., Kenney S. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J. Virol. 2000, 74:1224-1233.
2. Anisimova E., Saemundsen A.K., Roubal J., Vonka V., Klein G. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines. J. Gen. Virol. 1982, 58:163-171.
3. Bhende P.M., Dickerson S.J., Sun X., Feng W.H., Kenney S.C. X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J. Virol. 2007, 81:7363-7370.
4. Bresnahan W.A., Boldogh I., Thompson E.A., Albrecht T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 1996, 224:150-160.
5. Cayrol C., Flemington E. G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta. J. Biol. Chem. 1996, 271:31799-31802.
6. Cayrol C., Flemington E.K. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 1996, 15:2748-2759.
7. Chang S.S., Lo Y.C., Chua H.H., Chiu H.Y., Tsai S.C., Chen J.Y., Lo K.W., Tsai C.H. Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression. J. Virol. 2008, 82:7745-7751.
8. Darr C.D., Mauser A., Kenney S. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J. Virol. 2001, 75:6135-6142.
9. Farrell P.J., Allan G.J., Shanahan F., Vousden K.H., Crook T. p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J. 1991, 10:2879-2887.
10. Feederle R., Kost M., Baumann M., Janz A., Drouet E., Hammerschmidt W., Delecluse H.J. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 2000, 19:3080-3089.
11. Felsani A., Mileo A.M., Paggi M.G. Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 2006, 25:5277-5285.
12. Flemington E., Speck S.H. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 1990, 64:1227-1232.
13. Flemington E., Speck S.H. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 1990, 64:1217-1226.
14. Flemington E.K. Herpesvirus lytic replication and the cell cycle: arresting new developments. J. Virol. 2001, 75:4475-4481.
15. Garner E., Raj K. Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death. Cell Cycle 2008, 7:277-282.
16. Holley-Guthrie E.A., Quinlivan E.B., Mar E.C., Kenney S. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators. BRLF1 and BZLF1, in a cell-specific manner. J. Virol. 1990, 64:3753-3759.
17. Hume A.J., Finkel J.S., Kamil J.P., Coen D.M., Culbertson M.R., Kalejta R.F. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 2008, 320:797-799.
18. Hume A.J., Kalejta R.F. Regulation of the retinoblastoma proteins by the human herpesviruses. Cell. Div. 2009, 4:1.
19. Johnson D.G., Schwarz J.K., Cress W.D., Nevins J.R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993, 365:349-352.
20. Karimi L., Crawford D.H., Speck S., Nicholson L.J. Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus. J. Gen. Virol. 1995, 76:759-765.
21. Kudoh A., Fujita M., Kiyono T., Kuzushima K., Sugaya Y., Izuta S., Nishiyama Y., Tsurumi T. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J. Virol. 2003, 77:851-861.
22. Lee C., Cho Y. Interactions of SV40 large T antigen and other viral proteins with retinoblastoma tumour suppressor. Rev. Med. Virol. 2002, 12:81-92.
23. Li D., Qian L., Chen C., Shi M., Yu M., Hu M., Song L., Shen B., Guo N. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. J. Immunol. 2009, 182:1799-1809.
24. Liu G., Lozano G. p21 stability: linking chaperones to a cell cycle checkpoint. Cancer Cell 2005, 7:113-114.
25. Mauser A., Holley-Guthrie E., Simpson D., Kaufmann W., Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block. J. Virol. 2002, 76:10030-10037.
26. Mauser A., Holley-Guthrie E., Zanation A., Yarborough W., Kaufmann W., Klingelhutz A., Seaman W.T., Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J. Virol. 2002, 76:12543-12552.
27. Mauser A., Saito S., Appella E., Anderson C.W., Seaman W.T., Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J. Virol. 2002, 76:12503-12512.
28. Miller G., El-Guindy A., Countryman J., Ye J., Gradoville L. Lytic cycle switches of oncogenic human gammaherpesviruses. Adv. Cancer. Res. 2007, 97:81-109.
29. Moghaddam A., Rosenzweig M., Lee-Parritz D., Annis B., Johnson R.P., Wang F. An animal model for acute and persistent Epstein-Barr virus infection. Science 1997, 276:2030-2033.
30. O'Nions J., Allday M.J. Deregulation of the cell cycle by the Epstein-Barr virus. Adv. Cancer. Res. 2004, 92:119-186.
31. Quinlivan E.B., Holley-Guthrie E.A., Norris M., Gutsch D., Bachenheimer S.L., Kenney S.C. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter. BMRF1. Nucleic Acids Res. 1993, 21:1999-2007.
32. Ragoczy T., Miller G. Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes. J. Virol. 1999, 73:9858-9866.
33. Ragoczy T., Miller G. Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites. J. Virol. 2001, 75:5240-5251.
34. Rodriguez A., Jung E.J., Flemington E.K. Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents. J. Virol. 2001, 75:4482-4489.
35. Schwarzmann F., Jager M., Prang N., Wolf H. The control of lytic replication of Epstein-Barr virus in B lymphocytes (Review). Int. J. Mol. Med. 1998, 1:137-142.
36. Sinclair A.J., Brimmell M., Shanahan F., Farrell P.J. Pathways of activation of the Epstein-Barr virus productive cycle. J. Virol. 1991, 65:2237-2244.
37. Staudt M.R., Dittmer D.P. The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Curr. Top. Microbiol. Immunol. 2007, 312:71-100.
38. Sun C.C., Thorley-Lawson D.A. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J. Virol. 2007, 81:13566-13577.
39. Swanton C., Jones N. Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products. Int. J. Exp. Pathol. 2001, 82:3-13.
40. Swenson J.J., Mauser A.E., Kaufmann W.K., Kenney S.C. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J. Virol. 1999, 73:6540-6550.
41. Takada K., Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 1989, 63:445-449.
42. Thorley-Lawson D.A., Duca K.A., Shapiro M. Epstein-Barr virus: a paradigm for persistent infection-for real and in virtual reality. Trends. Immunol. 2008, 29:195-201.
43. Wu F.Y., Chen H., Wang S.E., ApRhys C.M., Liao G., Fujimuro M., Farrell C.J., Huang J., Hayward S.D., Hayward G.S. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle. J. Virol. 2003, 77:1481-1500.
44. Zacny V.L., Wilson J., Pagano J.S. The Epstein-Barr virus immediate-early gene product: BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle. J. Virol. 1998, 72:8043-8051.
45. Zeng Y., Middeldorp J., Madjar J.J., Ooka T. A major DNA binding protein encoded by BALF2 open reading frame of Epstein-Barr virus (EBV) forms a complex with other EBV DNA-binding proteins: DNAase, EA-D, and DNA polymerase. Virology 1997, 239:285-295.
46. Zhang Q., Gutsch D., Kenney S. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell. Biol. 1994, 14:1929-1938.